User:Mr. Ibrahem/Reteplase

Reteplase, trade names include Retavase, is a thrombolytic medication primarily used to treat heart attacks. It may also be used to treat certain pulmonary embolisms. It is given by injection into a vein.

Common side effects include bleeding. Other side effects may include allergic reactions and cholesterol embolism. Safety in pregnancy is unclear. It is a recombinant protein form of the human tissue plasminogen activator.

Reteplase was approved for medical use in the United States and Europe in 1996. In the United States it costs about 3,600 USD per dose as of 2021.